Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube
 

Journal of Vaccines & Vaccination


Open Access
 
ISSN: 2157-7560
 
 
 
HOME » VACCINES-VACCINATION
French Language  |  English
 
 
 
 
 

Upcoming Event

 

About the Journal

Indexed in 

 

flyer image Editor-in-Chief
Nikolai Petrovsky

Professor
Director of Endocrinology Medicine
Flinders University
Australia
Tel: +61 8 82044572
 
Impact Factor: 1.51*
Index Copernicus Value: 6.31
flyer image
A vaccine is a biological preparation intended to produce immunity to a disease by stimulating the production of antibodies. Vaccination is the administration of vaccines to develop adaptive immunity in an individual against a disease. The Journal of Vaccines & Vaccination provides an open access platform that emphasizes on the clinical effectiveness of new vaccines in treating various infectious diseases.
 
Journal of Vaccines & Vaccination is a peer reviewed open access Journal publishing then articles on different classification keywords like Human Vaccine Trials, Veterinary Vaccines, Cancer Vaccines, Vaccine Adjuvants, Vaccine regulatory issues, Preclinical vaccine studies, Childhood vaccines, HIV vaccines, Malaria vaccines, TB vaccines, etc., Articles published in this journal are subjected to rigorous review and revision process before being accepted for publication, to maintain quality and the standards set for academic journals. This Journal ensures the barrier-free distribution of its content through online free access and thus helps in improving the citations for authors and attaining a good impact factor.
 
Journal of Vaccines & Vaccination publishes discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc., The journal is using Editorial Manager System for peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Vaccines & Vaccination or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication.
 
OMICS Group International is publishing 300 open access journals with the support of about 25000 editorial board members. Journal of Vaccines & Vaccination is one among the best open access journals. OMICS Group International is also pioneer and leading scientific event organizer, conducting 100 conferences per year worldwide and has already signed 100 scientific Associations to make health care and scientific information open access.
 
Journal of Vaccines & Vaccination is organizing 4th International Conference on Vaccines & Vaccination during September 24-26, 2014 at Valencia, Spain with the theme "Recent Innovations and Benchmark Practices in Vaccines & Vaccination".
 

Submit manuscript at http://www.editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at editor.jvv@omicsonline.org
 
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y

 

 

Recently published articles

“Oral Vaccine Antigen Induced Immune Response Signalling Pathways: Current and Future Perspectives”

Anoop Kumar, Neelima Sharma, Sneha Singh, Sasmal D and Abhimanyu Dev

 
Probiotics and Vaccination in Children

Michele Miraglia del Giudice, Salvatore Leonardi, Francesca Galdo, Annalisa Allegorico, Martina Filippelli, Teresa Arrigo, Carmelo Salpietro, Mario La Rosa, Chiara Valsecchi, Sara Carlotta Tagliacarne, Anna Maria Castellazzi and Gian Luigi Marseglia

 
Genomic CpG Enrichment of Oncolytic Parvoviruses as a Potent Anticancer Vaccination Strategy for the Treatment of Pancreatic Adenocarcinoma

Svitlana P. Grekova, Marc Aprahamian, Nathalia A. Giese, Gaetan Bour, Thomas Giese, Annabel Grewenig, Barbara Leuchs, Rita Hörlein, Anette Heller, Assia L. Angelova, Jean Rommelaere and Zahari Raykov

 
What are the Implications of Distinct HPV Genotypes in Women of Different Ethnic/Racial Ancestry?

Adriana C. Vidal, Susan K. Murphy and Cathrine Hoyo

 
Campylobacter jejuni as a Cause of Acute Infectious Thyroiditis, on a Background of SLE-related End Stage Renal Failure and CMV Viraemia: A Case Report and Review of the Literature

Diggins B, Diaz-Cano SJ and Schulte KM

 
Survivin as a Cancer Vaccine Target

Michael J Ciesielski, Jingxin Qiu and Robert A Fenstermaker

 
Immunogenicity and Safety of Combined Tetanus, Reduced Diphtheria, Acellular Pertussis Vaccine when Co-Administered with Quadrivalent Meningococcal Conjugate and Human Papillomavirus Vaccines in Healthy Adolescents

Roberto Gasparini, William Johnston, Michele Conversano, Alan Garscadden, David Alexanderian, Noemi Giglioli, Sandra Percell, Linda Han and Igor Smolenov

 
Adverse Events Following Immunisation (AEFI) Surveillance in Kwekwe District, Midlands Province, Zimbabwe, 2009-2010

Muchekeza M, Chimusoro A , Nomagugu Ncube and Kufakwanguzvarova W Pomerai

 
 
 
 
 
 
© 2008–2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version